Literature DB >> 3421753

A retrospective analysis of 3 year's experience of an interdisciplinary approach to gallstone disease including shock-waves.

G Heberer1, G Paumgartner, T Sauerbruch, M Sackmann, H J Krämling, M Delius, W Brendel.   

Abstract

1206 patients with gallstone disease were treated between January 1985 and December 1987, using an interdisciplinary concept that included surgery, endoscopic sphincterotomy, and extracorporeal shock-wave lithotripsy (ESWL). Twenty-five per cent of the patients who were admitted for gallbladder stones were treated by ESWL, whereas 75% underwent surgery. Mortality of elective treatment for gallbladder stones amounted to 0.25% (0.4% in surgery, 0% in ESWL). Postoperative complication rate was low (4.2% in surgery, 7.0% in ESWL). After ESWL treatment, 80% of the patients were free of stones after a follow-up period of 1 year. Recurrence rate in these patients amounted up to 10%; in seven of 70 patients, mean follow-up period was 6 months after complete disappearance of stones. Twenty-seven per cent of all patients who were admitted for bile duct stones underwent surgery, whereas in the other 73%, calculi were removed via endoscopy. ESWL treatment was used additionally, if necessary. Fragments were left behind in three of 75 patients (4.0%) after surgical treatment, and in 7 of 200 patients (3.5%) after endoscopic and ESWL treatment, respectively. In the latter group, three patients (1.5%) required an additional operation. There were no deaths in either of the groups. The use of ESWL for treatment of gallbladder stones needs to be evaluated in long-term follow-up studies. Thus far, surgery remains the dominating method. Endoscopic procedures, eventually combined with ESWL, represent the preferred treatment for patients with bile duct stones.

Entities:  

Mesh:

Year:  1988        PMID: 3421753      PMCID: PMC1493655          DOI: 10.1097/00000658-198809000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  [Endoscopic sphincterotomy of the papilla of vater and extraction of stones from the choledochal duct (author's transl)].

Authors:  M Classen; L Demling
Journal:  Dtsch Med Wochenschr       Date:  1974-03-15       Impact factor: 0.628

2.  Long-term results with cholecystolithotomy.

Authors:  S Norrby; J Schönebeck
Journal:  Acta Chir Scand       Date:  1970

3.  [Therapy of cholelithiasis].

Authors:  T Sauerbruch; G Paumgartner
Journal:  Internist (Berl)       Date:  1986-10       Impact factor: 0.743

4.  Shock waves for gallstones: animal studies.

Authors:  W Brendel; G Enders
Journal:  Lancet       Date:  1983-05-07       Impact factor: 79.321

Review 5.  Trends in surgical treatment of calculous disease of the biliary tract.

Authors:  F Glenn
Journal:  Surg Gynecol Obstet       Date:  1975-06

Review 6.  Endoscopic management of bile duct stones; (apples and oranges).

Authors:  P B Cotton
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

7.  Medical treatment of cholesterol gallstones by bile desaturating agents.

Authors:  A F Hofmann
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

8.  Endoscopic management of choledocholithiasis.

Authors:  L Safrany; P B Cotton
Journal:  Surg Clin North Am       Date:  1982-10       Impact factor: 2.741

9.  Endoscopic treatment of biliary-tract diseases. An international study.

Authors:  L Safrany
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

10.  Fragmentation of gallstones by extracorporeal shock waves.

Authors:  T Sauerbruch; M Delius; G Paumgartner; J Holl; O Wess; W Weber; W Hepp; W Brendel
Journal:  N Engl J Med       Date:  1986-03-27       Impact factor: 91.245

View more
  13 in total

1.  Aggressive extracorporeal shock wave lithotripsy of gall bladder stones within wider treatment criteria: fragmentation rate and early results.

Authors:  G Meiser; M Heinerman; G Lexer; O Boeckl
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

2.  Recent results of elective open cholecystectomy in a North American and a European center. Comparison of complications and risk factors.

Authors:  P A Clavien; J R Sanabria; G Mentha; F Borst; L Buhler; B Roche; R Cywes; R Tibshirani; A Rohner; S M Strasberg
Journal:  Ann Surg       Date:  1992-12       Impact factor: 12.969

3.  The economic burden of gallstone lithotripsy. Will cost determine its fate?

Authors:  W H Nealon; F Urrutia; D Fleming; J C Thompson
Journal:  Ann Surg       Date:  1991-06       Impact factor: 12.969

Review 4.  The challenge of the bile duct in 1990.

Authors:  A L Peel
Journal:  Ann R Coll Surg Engl       Date:  1990-05       Impact factor: 1.891

5.  Laparoscopic laser cholecystectomy. A comparison with mini-lap cholecystectomy.

Authors:  E J Reddick; D O Olsen
Journal:  Surg Endosc       Date:  1989       Impact factor: 4.584

6.  Who should conduct extracorporeal shock-wave biliary lithotripsy studies?

Authors:  A Ertan; R E Hernandez; R R Schade; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

7.  Cholecystectomy. The impact of socioeconomic change.

Authors:  K D Saunders-Kirkwood; B Aizen; J E Thompson; M J Zinner; J A Cates; R Bennion; J Gill; F Boudi; J J Roslyn
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

8.  Open cholecystectomy. A contemporary analysis of 42,474 patients.

Authors:  J J Roslyn; G S Binns; E F Hughes; K Saunders-Kirkwood; M J Zinner; J A Cates
Journal:  Ann Surg       Date:  1993-08       Impact factor: 12.969

9.  Lovastatin inhibits gallstone formation in the cholesterol-fed prairie dog.

Authors:  K D Saunders; J A Cates; M Z Abedin; S Rege; S F Festekdjian; W Howard; J J Roslyn
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

Review 10.  Extracorporeal shockwave lithotripsy of gallstones. Possibilities and limitations.

Authors:  H Vergunst; O T Terpstra; K Brakel; J S Laméris; M van Blankenstein; F H Schröder
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.